Odyssey Therapeutics Climbs 11% After $304 Million US IPO
Odyssey Therapeutics Inc. shares jumped 11% in its trading debut, after the biopharmaceutical company raised $304 million in an upsized US initial public offering and private placement.
By Avalon Pernell · Bloomberg
Odyssey Therapeutics Inc. shares jumped 11% in its trading debut, after the biopharmaceutical company raised $304 million in an upsized US initial public offering and private placement.